Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients

Transplantation. 2021 Dec 1;105(12):e282. doi: 10.1097/TP.0000000000003942.
No abstract available

Publication types

  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Immunocompromised Host
  • SARS-CoV-2
  • Vaccines*

Substances

  • Vaccines